Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-03-20
1997-01-21
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514323, 514339, 514410, A61K 3140, A61K 3144, A61K 31445, A61K 31535
Patent
active
055959911
ABSTRACT:
The present invention provides a method for the treatment of helminthiasis which comprises administering to an infected host an effective amount of nodulisporic acid or a analog thereof.
REFERENCES:
patent: 5339582 (1995-03-01), Dombrowski
Michael Bruce F.
Ostlind Dan A.
Shoop Wesley
Merck & Co. , Inc.
Rose David L.
Spivack Phyllis G.
Yang Mollie M.
LandOfFree
Anthelmintic use of nodulisporic acid and analogs thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthelmintic use of nodulisporic acid and analogs thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthelmintic use of nodulisporic acid and analogs thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324332